Physical Therapists in Friendship, WI Accepting Medicare
5 Physical Therapists found. Showing 1 - 5
 Mary H. Moll, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 402 W. Lake St., Friendship, WI 53934 Phone: 608-339-3331 |
 Kevin B. Beaver, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 402 W. Lake St., Friendship, WI 53934 Phone: 608-339-3331 |
Kari A. Gatterman, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 402 W. Lake St., Friendship, WI 53934 Phone: 608-339-3331 |
Mary L. Fendt, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 402 W. Lake St., Friendship, WI 53934 Phone: 608-339-3331 |
Mr. Jason Matthew Wolbers, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 S Park Ave, Friendship, WI 53934 Phone: 608-339-3361 |
News Archive
Tenn. lawmaker proposes bill that would require HIV testing among prison inmates prior to release
Tennessee state Rep. Brenda Gilmore (D) has introduced a bill (H.B. 52) that would require HIV tests for prison inmates before their release as part of a larger plan to address the spread of HIV/AIDS in the state, WSMV.com reports. According to Gilmore, the plan will focus on blacks, who comprise 64% of new HIV cases in the state but only 13% of the population.
OR Productivity launches new robotic surgical arms
A UK company, which is increasing the quality and bringing down the costs of keyhole (laparoscopic) surgical procedures with robotic assistance, has unveiled its new system at the Annual American College of Surgeons Clinical Congress.
Humana second quarter consolidated revenues rises 10% to $8.65 billion
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended June 30, 2010 (2Q10) of $2.00, above management's guidance of $1.65 to $1.70. The 2Q10 results compared to EPS of $1.67 for the quarter ended June 30, 2009 (2Q09). For the six months ended June 30, 2010 (1H10) the company reported $3.52 in EPS compared to $2.89 for the six months ended June 30, 2009 (1H09).
Trial shows Elitek significantly reduces plasma uric acid levels versus Allopurinol in adults with hematologic cancers at risk for tumor Lysis syndrome
Sanofi-aventis has announced results of a randomized phase III study presented at the 50th Annual Meeting of the American Society of Hematology.
› Verified 3 days ago
Physical Therapists
Occupational Therapists
Optometrists
Speech-Language Pathologists